These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 22951238)
1. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update. Flockhart DA J Clin Psychiatry; 2012; 73 Suppl 1():17-24. PubMed ID: 22951238 [TBL] [Abstract][Full Text] [Related]
2. The transdermal delivery system of monoamine oxidase inhibitors. VanDenBerg CM J Clin Psychiatry; 2012; 73 Suppl 1():25-30. PubMed ID: 22951239 [TBL] [Abstract][Full Text] [Related]
3. The use of monoamine oxidase inhibitors in primary care. Culpepper L J Clin Psychiatry; 2012; 73 Suppl 1():37-41. PubMed ID: 22951241 [TBL] [Abstract][Full Text] [Related]
4. The role of monoamine oxidase inhibitors in depression treatment guidelines. Thase ME J Clin Psychiatry; 2012; 73 Suppl 1():10-6. PubMed ID: 22951237 [TBL] [Abstract][Full Text] [Related]
5. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art. Rapaport MH J Clin Psychiatry; 2007; 68 Suppl 8():42-6. PubMed ID: 17640157 [TBL] [Abstract][Full Text] [Related]
6. MAOIs and transdermal delivery. Vandenberg CM J Clin Psychiatry; 2012 Sep; 73(9):e28. PubMed ID: 23059160 [TBL] [Abstract][Full Text] [Related]
7. Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults. Shulman KI; Fischer HD; Herrmann N; Huo CY; Anderson GM; Rochon PA J Clin Psychiatry; 2009 Dec; 70(12):1681-6. PubMed ID: 19852903 [TBL] [Abstract][Full Text] [Related]
8. Discussion: a fresh look at monoamine oxidase inhibitors for depression. Cohen LJ; Sclar DA; Culpepper L; Flockhart DA; Hirschfeld RM; Thase ME; VanDenBerg CM J Clin Psychiatry; 2012; 73 Suppl 1():42-5. PubMed ID: 22951242 [No Abstract] [Full Text] [Related]
9. Tyramine and new monoamine oxidase inhibitor drugs. Simpson GM; de Leon J Br J Psychiatry Suppl; 1989 Oct; (6):32-7. PubMed ID: 2695125 [TBL] [Abstract][Full Text] [Related]
10. Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants. Stahl SM; Felker A CNS Spectr; 2008 Oct; 13(10):855-70. PubMed ID: 18955941 [TBL] [Abstract][Full Text] [Related]
11. MAOIs: issues in treatment adherence and rates of treatment failure. Cohen LJ; Sclar DA J Clin Psychiatry; 2013 Jan; 74(1):e02. PubMed ID: 23419230 [TBL] [Abstract][Full Text] [Related]
13. Issues in adherence to treatment with monoamine oxidase inhibitors and the rate of treatment failure. Cohen LJ; Sclar DA J Clin Psychiatry; 2012; 73 Suppl 1():31-6. PubMed ID: 22951240 [TBL] [Abstract][Full Text] [Related]
15. Current place of monoamine oxidase inhibitors in the treatment of depression. Shulman KI; Herrmann N; Walker SE CNS Drugs; 2013 Oct; 27(10):789-97. PubMed ID: 23934742 [TBL] [Abstract][Full Text] [Related]
16. What is the bottom line for dietary guidelines when taking monoamine oxidase inhibitors? Marcason W J Am Diet Assoc; 2005 Jan; 105(1):163. PubMed ID: 15635366 [No Abstract] [Full Text] [Related]
18. Introduction: a fresh look at monoamine oxidase inhibitors for depression. Cohen LJ; Sclar DA J Clin Psychiatry; 2012; 73 Suppl 1():3-4. PubMed ID: 22951235 [No Abstract] [Full Text] [Related]
19. Tyramine and irreversible monoamine oxidase inhibitors in clinical practice. Cooper AJ Br J Psychiatry Suppl; 1989 Oct; (6):38-45. PubMed ID: 2695126 [TBL] [Abstract][Full Text] [Related]
20. [Rational use of antidepressants in general medicine]. Verbanck P; Cnockaert P Rev Med Brux; 1996 Sep; 17(4):224-9. PubMed ID: 8927850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]